Bavarian Nordic, Pharmexa deal

Bavarian Nordic acquired from Pharmexa full rights to MVA-BN- HER2 for an undisclosed sum. The companies partnered in 2003 to jointly develop Pharmexa's HER2 DNA AutoVac compound with Bavarian Nordic'...